.avif)
SAN DIEGO, [December 11, 2017] (Business Wire) Scientist.com, the world’s leading online marketplace for outsourced scientific services, today announced that it is celebrating its 10th anniversary. Since its founding in 2007, the company has worked closely with AstraZeneca, Pfizer, Novartis and ten other large pharmaceutical partners to build a research platform capable of dramatically improving how medical research is done. Scientist.com now has more than 2,250 pre-signed global suppliers in its network, enabling researchers to custom design and purchase thousands of research services in just a few mouse clicks. In 2017, the company raised $24M in VC funding and ranked no. 155 on INC Magazine’s list of the 5000 fastest-growing privately-owned companies in America.
“The Scientist.com marketplace has the power to disrupt the trillion-dollar pharmaceutical industry,” stated Chris Petersen, Scientist.com’s CTO and Founder. “We are pioneering a radically more efficient approach to medical research that greatly speeds up drug discovery and substantially reduces the cost of bringing new cures to market.”
Traditionally, pharmaceutical research experiments were carried out by hundreds of internal researchers working in huge company-owned laboratories. By enabling researchers to easily outsource experiments that were previously done in-house, Scientist.com has created a new, more effective drug research process. The marketplace saves time, reduces costs, improves access to the latest research tools and helps ensure compliance with internal and governmental regulations.
“From inception, our mission has been to empower and connect scientists worldwide,” stated Kevin Lustig, PhD, Scientist.com’s CEO and Founder. “Today, a single highly-experienced drug hunter can use the Scientist.com marketplace to communicate with thousands of global experts and carry out an entire drug discovery project from concept to clinic, without ever requiring physical access to a laboratory.”
.webp)
Scientist.com
Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。
私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。
現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。